Very-Early Onset Chronic Active Colitis with Heterozygous Variants in LRBA1 and CARD11, a Case of "Immune TOR-Opathies"

Fetal Pediatr Pathol. 2023 Apr;42(2):297-306. doi: 10.1080/15513815.2022.2088912. Epub 2022 Jun 24.

Abstract

Background: A small subset of cases of inflammatory bowel disease (IBD) occurs as a result of single gene defects, and typically occurs in young or very young pediatric patients, referred to as "monogenic very-early onset IBD (VEO-IBD)". The gene variants leading to monogenic VEO-IBD are often associated with primary immunodeficiency syndromes.

Case report: A six year-old girl presented to our gastroenterology clinic with LRBA deficiency with a heterozygous mutation at c.1399 A > G, p Met467Val, histopathologic chronic active colitis without granulomas and clinical chronic colitis. Her gastrointestinal symptoms began at age 5 with bloody diarrhea, abdominal pain and weight loss. Whole exome sequencing revealed a CARD11 heterozygous de novo mutation (c.220 + 1G > A). She was in clinical remission on only abatacept.

Discussion: We present a case of monogenic VEO-IBD associated with two heterozygous variants in LRBA1 and CARD11, both considered as key players in the newly proposed "immune TOR-opathies".

Keywords: CARD11; LRBA1; Very early onset; colitis; immune TOR-opathies; inflammatory bowel disease; monogenic.

Publication types

  • Case Reports

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Age of Onset
  • CARD Signaling Adaptor Proteins / genetics
  • Child
  • Child, Preschool
  • Colitis* / diagnosis
  • Colitis* / genetics
  • Female
  • Guanylate Cyclase / genetics
  • Heterozygote
  • Humans
  • Inflammatory Bowel Diseases* / diagnosis
  • Inflammatory Bowel Diseases* / genetics
  • Mutation

Substances

  • CARD11 protein, human
  • Guanylate Cyclase
  • CARD Signaling Adaptor Proteins
  • LRBA protein, human
  • Adaptor Proteins, Signal Transducing